|
G |
Acan |
aggrecan |
affects expression |
EXP |
Amiloride affects the expression of ACAN mRNA |
CTD |
PMID:20454829 |
|
NCBI chr 1:132,981,582...133,044,416
Ensembl chr 1:132,981,582...133,043,627
|
|
G |
Agt |
angiotensinogen |
multiple interactions increases expression |
EXP ISO |
Amiloride inhibits the reaction [AGT protein results in increased expression of ATP1A1 mRNA] Amiloride results in increased expression of AGT protein modified form |
CTD |
PMID:7357812 PMID:14630723 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
Amiloride results in decreased phosphorylation of and results in decreased activity of AKT1 protein; Okadaic Acid inhibits the reaction [Amiloride results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:15607733 PMID:16059913 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alb |
albumin |
multiple interactions |
EXP |
Amiloride inhibits the reaction [ALB protein results in increased expression of CCL2 protein] |
CTD |
PMID:11340305 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aoc1 |
amine oxidase, copper containing 1 |
affects binding multiple interactions decreases activity |
ISO EXP |
Amiloride binds to AOC1 protein Amiloride inhibits the reaction [Phenylamil binds to Aoc1 protein] Amiloride binds to Aoc1 protein Amiloride inhibits the reaction [AOC1 protein results in increased degradation of Putrescine] Amiloride results in decreased activity of AOC1 protein |
CTD RGD |
PMID:2217167 PMID:8144586 PMID:8375402 PMID:8375402 |
RGD:724757, RGD:724757 |
NCBI chr 4:77,812,260...77,831,846
Ensembl chr 4:77,812,260...77,831,840
|
|
G |
Asic3 |
acid sensing ion channel subunit 3 |
affects response to substance |
ISO |
ASIC3 protein affects the susceptibility to Amiloride |
CTD |
PMID:12037186 |
|
NCBI chr 4:10,760,509...10,764,987
Ensembl chr 4:10,760,597...10,764,643
|
|
G |
Atp1a1 |
ATPase Na+/K+ transporting subunit alpha 1 |
multiple interactions |
EXP |
Amiloride inhibits the reaction [AGT protein results in increased expression of ATP1A1 mRNA] |
CTD |
PMID:14630723 |
|
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
|
|
G |
Atp6v1b1 |
ATPase H+ transporting V1 subunit B1 |
multiple interactions |
EXP |
[Furosemide co-treated with Amiloride] results in increased expression of ATP6V1B1 protein |
CTD |
PMID:17311909 |
|
NCBI chr 4:116,223,799...116,242,475
Ensembl chr 4:116,223,799...116,242,475
|
|
G |
Cacna1h |
calcium voltage-gated channel subunit alpha1 H |
multiple interactions |
ISO |
Amiloride inhibits the reaction [CACNA1H protein results in increased transport of Calcium] |
CTD |
PMID:9930755 PMID:11897840 |
|
NCBI chr10:14,390,104...14,448,204
Ensembl chr10:14,390,113...14,448,376
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
multiple interactions |
ISO |
Amiloride inhibits the reaction [Acids results in increased secretion of CALCA protein] |
CTD |
PMID:20100279 |
|
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO EXP |
Amiloride promotes the reaction [TNFSF10 protein results in increased activity of CASP3 protein]; Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP3 protein] Amiloride inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] |
CTD |
PMID:15607733 PMID:16059913 PMID:34656704 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
Amiloride promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein]; Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein] |
CTD |
PMID:15607733 PMID:16059913 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP9 protein] |
CTD |
PMID:16059913 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions decreases expression |
ISO EXP |
Amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein] Amiloride results in decreased expression of CCL2 mRNA; Amiloride results in decreased expression of CCL2 protein Amiloride inhibits the reaction [ALB protein results in increased expression of CCL2 protein]; Amiloride inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Amiloride inhibits the reaction [Ouabain results in increased expression of CCL2 protein]; Sodium deficiency inhibits the reaction [Amiloride results in decreased expression of CCL2 mRNA]; Sodium deficiency inhibits the reaction [Amiloride results in decreased expression of CCL2 protein] |
CTD |
PMID:11340305 PMID:12107048 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
multiple interactions |
ISO |
Amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL3 protein] |
CTD |
PMID:11420121 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
Amiloride results in decreased expression of CCNB1 protein |
CTD |
PMID:9458082 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Cftr |
CF transmembrane conductance regulator |
increases activity |
ISO EXP |
Amiloride results in increased activity of CFTR protein Amiloride increases activity of Cftr protein in nasal cavity epithelium |
CTD RGD |
PMID:15246976 PMID:31942562 |
RGD:126928119 |
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
G |
Col2a1 |
collagen type II alpha 1 chain |
affects expression |
EXP |
Amiloride affects the expression of COL2A1 mRNA |
CTD |
PMID:20454829 |
|
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
multiple interactions |
ISO |
Amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CXCL2 protein] |
CTD |
PMID:11420121 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO |
Amiloride promotes the reaction [TNFSF10 protein affects the localization of CYCS protein] |
CTD |
PMID:15607733 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases activity |
ISO |
Amiloride results in decreased activity of CYP1A1 protein |
CTD |
PMID:33814510 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases activity |
ISO |
Amiloride results in decreased activity of CYP1B1 protein |
CTD |
PMID:33814510 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions |
ISO |
Amiloride inhibits the reaction [Tunicamycin results in increased expression of DDIT3] |
CTD |
PMID:20015086 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dysf |
dysferlin |
decreases expression |
ISO |
Amiloride results in decreased expression of DYSF mRNA |
CTD |
PMID:15535137 |
|
NCBI chr 4:116,490,877...116,690,709
Ensembl chr 4:116,490,616...116,690,709
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
increases phosphorylation |
ISO |
Amiloride results in increased phosphorylation of EIF2A protein |
CTD |
PMID:20015086 |
|
NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
decreases phosphorylation |
ISO |
Amiloride results in decreased phosphorylation of ERBB2 protein |
CTD |
PMID:16059913 |
|
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions |
ISO |
Amiloride inhibits the reaction [Tunicamycin results in increased phosphorylation of and results in increased activity of ERN1 protein] |
CTD |
PMID:20015086 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions |
ISO |
Amiloride results in increased expression of FOS mRNA Amiloride inhibits the reaction [Acids results in increased expression of and results in increased localization of FOS protein] |
CTD |
PMID:12730611 PMID:16769263 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Grip1 |
glutamate receptor interacting protein 1 |
affects response to substance |
ISO |
GRIP1 gene SNP affects the susceptibility to Amiloride |
CTD |
PMID:25622337 |
|
NCBI chr 7:54,934,856...55,592,274
Ensembl chr 7:54,934,250...55,592,273
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions |
ISO |
Amiloride inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA]; Amiloride inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein] |
CTD |
PMID:20015086 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
Amiloride inhibits the reaction [IFNG protein results in increased expression of PLAUR mRNA] Amiloride inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with IFNG protein] results in increased secretion of IL12B protein] |
CTD |
PMID:11420121 PMID:12070711 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
ISO |
Amiloride inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with IFNG protein] results in increased secretion of IL12B protein] |
CTD |
PMID:11420121 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
Amiloride inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]]; Amiloride inhibits the reaction [IL1B protein results in increased expression of CXCL8 mRNA]; Amiloride inhibits the reaction [IL1B protein results in increased expression of SELE protein]; Amiloride inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK1 protein]; Amiloride inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK3 protein]; Amiloride inhibits the reaction [IL1B protein results in increased secretion of CXCL8 protein] |
CTD |
PMID:12065299 PMID:12107048 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Itgal |
integrin subunit alpha L |
multiple interactions |
ISO |
Amiloride inhibits the reaction [TNF protein results in increased expression of ITGAL mRNA]; Amiloride inhibits the reaction [TNF protein results in increased expression of ITGAL protein] |
CTD |
PMID:10198263 |
|
NCBI chr 1:181,918,183...181,955,735
Ensembl chr 1:181,918,183...181,955,732
|
|
G |
Klk1 |
kallikrein 1 |
multiple interactions increases response to substance |
ISO |
KLK1 protein affects the susceptibility to [Amiloride results in increased secretion of Sodium] KLK1 protein results in increased susceptibility to Amiloride |
CTD |
PMID:18086683 |
|
NCBI chr 1:94,642,644...94,646,760
Ensembl chr 1:94,642,687...94,646,754
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
Amiloride inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:12065299 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
Amiloride inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:12065299 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
Amiloride inhibits the reaction [azaspiracid results in increased phosphorylation of and affects the localization of MAPK8 protein] |
CTD |
PMID:19815690 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions |
ISO |
Amiloride inhibits the reaction [azaspiracid results in increased phosphorylation of and affects the localization of MAPK9 protein] |
CTD |
PMID:19815690 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Myf5 |
myogenic factor 5 |
increases expression |
ISO |
Amiloride results in increased expression of MYF5 mRNA |
CTD |
PMID:15535137 |
|
NCBI chr 7:42,802,946...42,806,177
Ensembl chr 7:42,802,946...42,806,177
|
|
G |
Myl12b |
myosin light chain 12B |
decreases phosphorylation |
ISO |
Amiloride results in decreased phosphorylation of MRLC2 protein |
CTD |
PMID:11078707 |
|
NCBI chr 9:110,873,855...110,888,187
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
Amiloride inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]]; Amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of NFKB1 protein] |
CTD |
PMID:12065299 PMID:12107048 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
Amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased degradation of and results in decreased expression of NFKBIA protein] |
CTD |
PMID:12107048 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
Lipopolysaccharides inhibits the reaction [Amiloride results in increased expression of NOS2] |
CTD |
PMID:21356098 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]; Okadaic Acid inhibits the reaction [Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]] |
CTD |
PMID:15607733 PMID:16059913 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pdpk1 |
3-phosphoinositide dependent protein kinase-1 |
decreases phosphorylation |
ISO |
Amiloride results in decreased phosphorylation of PDPK1 protein |
CTD |
PMID:16059913 |
|
NCBI chr10:13,105,435...13,182,664
Ensembl chr10:13,105,498...13,174,623
|
|
G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
decreases uptake |
ISO |
Amiloride results in decreased uptake of PDX1 protein |
CTD |
PMID:16405074 |
|
NCBI chr12:7,757,865...7,763,064
Ensembl chr12:7,757,865...7,763,064
|
|
G |
Pkd2 |
polycystin 2, transient receptor potential cation channel |
multiple interactions |
ISO |
Amiloride results in decreased activity of [PKD2 protein binds to PKD2 protein]; Amiloride results in decreased activity of [PKD2 protein binds to TRPC1 protein] |
CTD |
PMID:19193631 |
|
NCBI chr14:5,237,135...5,280,455
Ensembl chr14:5,237,135...5,280,825
|
|
G |
Plau |
plasminogen activator, urokinase |
multiple interactions decreases activity |
ISO |
Amiloride inhibits the reaction [PLAU protein results in increased degradation of PLG protein] Amiloride results in decreased activity of PLAU protein |
CTD |
PMID:8921802 PMID:11454671 PMID:14644129 |
|
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
multiple interactions |
ISO |
Amiloride inhibits the reaction [IFNA2 protein results in increased expression of PLAUR mRNA]; Amiloride inhibits the reaction [IFNG protein results in increased expression of PLAUR mRNA] |
CTD |
PMID:12070711 |
|
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
|
|
G |
Plg |
plasminogen |
multiple interactions |
ISO |
Amiloride inhibits the reaction [PLAU protein results in increased degradation of PLG protein] |
CTD |
PMID:14644129 |
|
NCBI chr 1:48,325,186...48,367,643
Ensembl chr 1:48,325,185...48,367,786
|
|
G |
Ppp1ca |
protein phosphatase 1 catalytic subunit alpha |
decreases phosphorylation multiple interactions |
ISO |
Amiloride results in decreased phosphorylation of PPP1CA protein Okadaic Acid inhibits the reaction [Amiloride results in decreased phosphorylation of PPP1CA protein] |
CTD |
PMID:16059913 |
|
NCBI chr 1:201,485,117...201,488,734
Ensembl chr 1:201,485,085...201,497,327
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO EXP |
Amiloride inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] Amiloride inhibits the reaction [Doxorubicin results in increased expression of PTGS2 protein] |
CTD |
PMID:17237260 PMID:34656704 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO EXP |
Amiloride inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]]; Amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of RELA protein] Amiloride inhibits the reaction [Doxorubicin results in increased expression of RELA protein] |
CTD |
PMID:12065299 PMID:12107048 PMID:34656704 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Scnn1a |
sodium channel epithelial 1 subunit alpha |
multiple interactions affects activity |
ISO EXP |
Amiloride inhibits the reaction [[SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] which results in increased transport of Sodium]; Amiloride results in decreased activity of [SCNN1A binds to SCNN1B binds to SCNN1G binds to SCNN1D]; Amiloride results in decreased activity of [SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] [farglitazar co-treated with Amiloride] results in increased expression of SCNN1A mRNA Amiloride affects the activity of SCNN1A protein |
CTD |
PMID:8617496 PMID:15475592 PMID:18398334 PMID:18665318 PMID:19359370 |
|
NCBI chr 4:158,122,962...158,146,184
Ensembl chr 4:158,122,962...158,146,181
|
|
G |
Scnn1b |
sodium channel epithelial 1 subunit beta |
multiple interactions affects activity |
ISO |
Amiloride inhibits the reaction [[SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] which results in increased transport of Sodium]; Amiloride results in decreased activity of [SCNN1A binds to SCNN1B binds to SCNN1G binds to SCNN1D]; Amiloride results in decreased activity of [SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] Amiloride affects the activity of SCNN1B protein |
CTD |
PMID:8617496 PMID:18398334 PMID:18665318 PMID:19359370 |
|
NCBI chr 1:176,430,063...176,484,451
Ensembl chr 1:176,430,103...176,484,451
|
|
G |
Scnn1g |
sodium channel epithelial 1 subunit gamma |
affects activity multiple interactions |
ISO |
Amiloride affects the activity of SCNN1G protein Amiloride inhibits the reaction [[SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] which results in increased transport of Sodium]; Amiloride results in decreased activity of [SCNN1A binds to SCNN1B binds to SCNN1G binds to SCNN1D]; Amiloride results in decreased activity of [SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] |
CTD |
PMID:8617496 PMID:18398334 PMID:18665318 PMID:19359370 |
|
NCBI chr 1:176,304,942...176,338,816
Ensembl chr 1:176,304,942...176,338,816
|
|
G |
Sele |
selectin E |
multiple interactions |
ISO |
Amiloride inhibits the reaction [IL1B protein results in increased expression of SELE protein] |
CTD |
PMID:12107048 |
|
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Slc12a4 |
solute carrier family 12 member 4 |
multiple interactions |
ISO |
Amiloride inhibits the reaction [SLC12A4 protein results in increased transport of Potassium] |
CTD |
PMID:11703599 |
|
NCBI chr19:33,838,418...33,860,369
Ensembl chr19:33,838,419...33,860,331
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
Amiloride inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc26a4 |
solute carrier family 26 member 4 |
multiple interactions |
EXP |
[Furosemide co-treated with Amiloride] affects the localization of SLC26A4 protein |
CTD |
PMID:17311909 |
|
NCBI chr 6:48,107,575...48,153,762
Ensembl chr 6:48,107,588...48,145,703
|
|
G |
Slc31a1 |
solute carrier family 31 member 1 |
multiple interactions |
ISO |
Amiloride inhibits the reaction [Cisplatin results in increased degradation of SLC31A1 protein] |
CTD |
PMID:17108132 |
|
NCBI chr 5:75,814,744...75,844,241
Ensembl chr 5:75,814,743...75,844,228
|
|
G |
Slc47a1 |
solute carrier family 47 member 1 |
decreases activity multiple interactions |
ISO |
Amiloride results in decreased activity of SLC47A1 protein Amiloride inhibits the reaction [SLC47A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:16928787 PMID:22419765 |
|
NCBI chr10:46,034,115...46,088,617
Ensembl chr10:46,034,122...46,087,637
|
|
G |
Slc47a2 |
solute carrier family 47 member 2 |
multiple interactions |
ISO |
Amiloride inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:22419765 |
|
NCBI chr10:45,990,806...46,033,937
Ensembl chr10:45,991,095...46,033,904
|
|
G |
Slc52a3 |
solute carrier family 52 member 3 |
multiple interactions |
EXP |
Amiloride inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin] |
CTD |
PMID:19122205 |
|
NCBI chr 3:140,498,924...140,515,845
Ensembl chr 3:140,509,473...140,514,096
|
|
G |
Slc9a1 |
solute carrier family 9 member A1 |
multiple interactions |
EXP |
Amiloride inhibits the reaction [Doxorubicin results in increased expression of SLC9A1 protein] |
CTD |
PMID:34656704 |
|
NCBI chr 5:145,576,341...145,629,630
Ensembl chr 5:145,576,334...145,629,624
|
|
G |
Slc9a2 |
solute carrier family 9 member A2 |
multiple interactions |
EXP |
[Amiloride results in decreased activity of SLC9A2 protein] which results in decreased transport of Chlorides; [Amiloride results in decreased activity of SLC9A2 protein] which results in decreased transport of Sodium |
CTD |
PMID:10958346 |
|
NCBI chr 9:42,932,001...43,014,447
Ensembl chr 9:42,931,346...43,014,444
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO EXP |
Amiloride inhibits the reaction [TNF protein results in increased expression of ITGAL mRNA]; Amiloride inhibits the reaction [TNF protein results in increased expression of ITGAL protein]; Lipopolysaccharides inhibits the reaction [Amiloride results in increased expression of TNF] Amiloride inhibits the reaction [Doxorubicin results in increased expression of TNF protein] |
CTD |
PMID:10198263 PMID:21356098 PMID:34656704 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
multiple interactions |
ISO |
Amiloride promotes the reaction [TNFSF10 protein affects the localization of CYCS protein]; Amiloride promotes the reaction [TNFSF10 protein results in increased activity of CASP3 protein]; Amiloride promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein]; Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP3 protein]; Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein]; Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP9 protein]; Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]; Okadaic Acid inhibits the reaction [Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]] |
CTD |
PMID:15607733 PMID:16059913 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
multiple interactions |
ISO |
Amiloride inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein] |
CTD |
PMID:15843607 |
|
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
|
|
G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
multiple interactions |
ISO |
Amiloride results in decreased activity of [PKD2 protein binds to TRPC1 protein] |
CTD |
PMID:19193631 |
|
NCBI chr 8:96,263,322...96,314,220
Ensembl chr 8:96,263,329...96,314,276
|
|
G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
decreases activity |
ISO |
Amiloride results in decreased activity of TRPC6 protein |
CTD |
PMID:11179201 |
|
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression |
ISO |
Amiloride results in decreased expression of VEGFA mRNA; Amiloride results in decreased expression of VEGFA protein |
CTD |
PMID:16884771 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Xbp1 |
X-box binding protein 1 |
multiple interactions |
ISO |
Amiloride inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA] |
CTD |
PMID:20015086 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
5-(N,N-hexamethylene)amiloride results in increased expression of DDIT3 mRNA |
CTD |
PMID:19302589 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Hsp90b1 |
heat shock protein 90 beta family member 1 |
affects expression |
ISO |
5-(N,N-hexamethylene)amiloride affects the expression of HSP90B1 mRNA |
CTD |
PMID:19302589 |
|
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
affects expression |
ISO |
5-(N,N-hexamethylene)amiloride affects the expression of HSPA5 mRNA |
CTD |
PMID:19302589 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
increases expression |
ISO |
5-(N,N-hexamethylene)amiloride results in increased expression of PPP1R15A mRNA |
CTD |
PMID:19302589 |
|
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression |
ISO |
5-(N,N-hexamethylene)amiloride results in increased expression of PTGS2 mRNA |
CTD |
PMID:19302589 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Serpinb1a |
serpin family B member 1A |
multiple interactions |
ISO |
5-(N,N-hexamethylene)amiloride results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1 protein modified form |
CTD |
PMID:25447644 |
|
NCBI chr17:31,590,695...31,599,102
Ensembl chr17:31,590,677...31,599,102
|
|
|
G |
Alb |
albumin |
decreases uptake |
ISO |
ethylisopropylamiloride results in decreased uptake of ALB protein |
CTD |
PMID:16313995 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aoc1 |
amine oxidase, copper containing 1 |
affects binding multiple interactions decreases activity |
ISO EXP |
ethylisopropylamiloride binds to AOC1 protein Ethylisopropylamiloride binds to Aoc1 protein Ethylisopropylamiloride inhibits the reaction [Phenylamil binds to Aoc1 protein] ethylisopropylamiloride results in decreased activity of AOC1 protein ethylisopropylamiloride inhibits the reaction [AOC1 protein results in increased degradation of Putrescine] |
CTD RGD |
PMID:2217167 PMID:8144586 PMID:8375402 PMID:8375402 |
RGD:724757, RGD:724757 |
NCBI chr 4:77,812,260...77,831,846
Ensembl chr 4:77,812,260...77,831,840
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
ethylisopropylamiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein] |
CTD |
PMID:12107048 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions |
EXP |
ethylisopropylamiloride inhibits the reaction [ferric nitrilotriacetate results in increased expression of COL1A1 protein]; ethylisopropylamiloride inhibits the reaction [iron(II)-ascorbic acid complex results in increased expression of COL1A1 protein] |
CTD |
PMID:11159895 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases activity |
ISO |
ethylisopropylamiloride results in decreased activity of CYP1A1 protein |
CTD |
PMID:15081870 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity |
ISO |
ethylisopropylamiloride results in decreased activity of CYP1A2 protein |
CTD |
PMID:15081870 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases activity |
ISO |
ethylisopropylamiloride results in decreased activity of CYP1B1 protein |
CTD |
PMID:15081870 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Fah |
fumarylacetoacetate hydrolase |
affects splicing |
ISO |
ethylisopropylamiloride affects the splicing of FAH mutant form |
CTD |
PMID:23895425 |
|
NCBI chr 1:138,548,830...138,571,599
Ensembl chr 1:138,548,834...138,571,505
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
ethylisopropylamiloride inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with IFNG protein] results in increased secretion of IL12B protein] |
CTD |
PMID:11420121 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
ISO |
ethylisopropylamiloride inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with IFNG protein] results in increased secretion of IL12B protein] |
CTD |
PMID:11420121 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
ethylisopropylamiloride inhibits the reaction [IL1B protein results in increased secretion of CXCL8 protein] |
CTD |
PMID:12065299 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
ethylisopropylamiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of NFKB1 protein] |
CTD |
PMID:12107048 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
ethylisopropylamiloride inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] |
CTD |
PMID:17237260 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
ethylisopropylamiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of RELA protein] |
CTD |
PMID:12107048 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Slc9a1 |
solute carrier family 9 member A1 |
decreases activity multiple interactions |
ISO EXP |
ethylisopropylamiloride results in decreased activity of SLC9A1 protein [ethylisopropylamiloride results in decreased activity of SLC9A1 protein] which results in increased abundance of Doxorubicin |
CTD |
PMID:12562776 PMID:15729714 PMID:17552965 |
|
NCBI chr 5:145,576,341...145,629,630
Ensembl chr 5:145,576,334...145,629,624
|
|
G |
Srsf3 |
serine and arginine rich splicing factor 3 |
increases expression |
ISO |
ethylisopropylamiloride results in increased expression of SRSF3 protein |
CTD |
PMID:17924536 |
|
NCBI chr20:7,091,928...7,101,860
Ensembl chr20:7,091,910...7,101,078
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression |
ISO |
ethylisopropylamiloride results in decreased expression of VEGFA mRNA; ethylisopropylamiloride results in decreased expression of VEGFA protein |
CTD |
PMID:16884771 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|